|
GOLIM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.04610000000116E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.974100E-04 |
| Normal-vs-Stage2 |
2.184400E-03 |
| Normal-vs-Stage3 |
1.72710999999381E-05 |
| Normal-vs-Stage4 |
6.046100E-04 |
| Stage1-vs-Stage2 |
7.990400E-01 |
| Stage1-vs-Stage3 |
1.577770E-01 |
| Stage1-vs-Stage4 |
4.870800E-01 |
| Stage2-vs-Stage3 |
4.583400E-01 |
| Stage2-vs-Stage4 |
7.308800E-01 |
| Stage3-vs-Stage4 |
7.328000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.011800E-04 |
| Normal-vs-AfricanAmerican |
7.594100E-02 |
| Normal-vs-Asian |
1.646260E-02 |
| Caucasian-vs-AfricanAmerican |
4.753400E-01 |
| Caucasian-vs-Asian |
6.982400E-01 |
| AfricanAmerican-vs-Asian |
7.438800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6797799999968E-05 |
| Normal-vs-Female |
2.614400E-04 |
| Male-vs-Female |
1.987030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.742650E-03 |
| Normal-vs-Age(41-60Yrs) |
5.93890000000208E-05 |
| Normal-vs-Age(61-80Yrs) |
1.52356999999492E-05 |
| Normal-vs-Age(81-100Yrs) |
5.654200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.368600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.253990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.078400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.998200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.906800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.174600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.313400E-01 |
| Classical-VS-Follicular |
1.240420E-03 |
| Classical-VS-Other |
2.242800E-01 |
| Classical-VS-Normal |
2.995200E-03 |
| Tall-VS-Follicular |
2.665000E-01 |
| Tall-VS-Other |
4.187600E-01 |
| Tall-VS-Normal |
1.436430E-03 |
| Follicular-VS-Other |
8.725800E-01 |
| Follicular-VS-Normal |
2.66270000048863E-07 |
| Other-VS-Normal |
1.030480E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.5173000002593E-07 |
| Normal-vs-N1 |
2.362100E-03 |
| N0-vs-N1 |
4.892400E-01 |
|
|
